Imbruvica
| Imbruvica | |
|---|---|
| Term | Imbruvica |
| Short definition | Imbruvica (im-BROO-vih-kuh) A medicine used alone or with other medicines to treat adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, Waldenstrom's macroglobulinemia (a type of non-Hodgkin lymphoma), mantle cell lymphoma or marginal zone lymphoma. It is also used to treat adults and children over 1 year old with chronic graft-versus-host disease. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Imbruvica - (pronounced) (im-BROO-vih-kuh) A medicine used alone or with other medicines to treat adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, Waldenstrom's macroglobulinemia (a type of non-Hodgkin lymphoma), mantle cell lymphoma or marginal zone lymphoma. It is also used to treat adults and children over 1 year old with chronic graft-versus-host disease. It is also being studied in the treatment of other types of cancer. Imbruvica blocks a protein called BTK, which can help prevent cancer cells from growing. It can also decrease the body's immune response. Imbruvica is a type of tyrosine kinase inhibitor. Also called ibrutinib
External links
- Medical encyclopedia article on Imbruvica
- Wikipedia's article - Imbruvica
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski